Abstract
We have investigated the possible involvement of endogenous corticosteroids in the maintenance of hypertension in aged lean and obese Zucker rats using the type II corticosteroid antagonist mifepristone. At 8 mo of age, the start of the study, obese Zuckers had been hypertensive for at least 2 mo (systolic blood pressure; 153 ± 4 vs. 136 ± 5 mmHg; n = 8–9; P < .05) and were hyperinsulinemic (756 ± 98 vs.193 ± 61 μU · ml−1) and hypercorticosteronemic (524 ± 83 vs. 260 ± 97 ng · ml−1) compared to their lean littermates. There were no differences in plasma renin activity between lean and obese animals and plasma renin activity was unaffected by any treatment. Oral treatment of obese rats with mifepristone (40.0 mg · kg−1 day−1 for 9 days) resulted in a gradual reduction in SBP to lean levels by day 9. Mifepristone treatment did not affect plasma insulin or corticosterone levels but resulted in a significant reduction in plasma aldosterone concentration. Mifepristone was without significant effect on systolic blood pressure in lean rats. Oral treatment of lean rats with corticosterone-21-acetate (3.0 mg · kg−1day−1 for 9 days) resulted in a rise in systolic blood pressure to levels similar to obese Zuckers after 9 days. Plasma insulin levels were unchanged but corticosterone immunoreactivity was significantly reduced. Plasma aldosterone levels were increased from 564 ± 3 to 802 ± 68 pg · ml−1. Our data suggest that raised glucocorticoids and aldosterone may be factors contributing to hypertension in obesity.
Footnotes
-
Send reprint requests to: Dr. John C. Clapham, Department of Vascular Biology, SmithKline Beecham Pharmaceuticals, The Frythe, Welwyn, Hertfordshire AL6 9AR, U.K.
- Abbreviations:
- SBP
- systolic blood pressure
- PRA
- plasma renin activity
- ANOVA
- analysis of variance
- Received July 22, 1996.
- Accepted April 8, 1997.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|